Coya Therapeutics, Inc. Balance Sheet
COYA|3 years of annual SEC 10-K data (FY2023-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Coya Therapeutics, Inc. had $50M in total assets and $43M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash & Equivalents | $46.8M | $38.3M | $32.6M |
| Current Assets | $49.9M | $44.3M | $41.2M |
| PP&E (Net) | $11.2K | $38.6K | $65.9K |
| Total Assets | $50.0M | $44.3M | $41.3M |
| Current Liabilities | $5.9M | $3.8M | $5.1M |
| Shareholders' Equity | $43.0M | $35.6M | -$8.4M |